{"transactions":[{"id":1008729,"issuer":{"id":7609,"kind":"organization","name":"Marker Therapeutics, Inc."},"owners":[{"id":73641,"kind":"person","name":"Corzo Kathryn Penkus","position":1,"cik":"0001884123","reported_name":"Corzo Kathryn Penkus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-04T22:09:13.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":147611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. The shares vest equally over thirty six (36) monthly installments, subject to the Reporting Person's continued service as a director. The option exercise price is the closing price on the date of the grant, October 31, 2025."}],"balance_after":147611,"derivative":{"exercise_price":0.9877,"expiration_date":"2035-10-31","underlying":"Common Stock","underlying_shares":147611},"source":{"system":"sec-edgar","filing":"0001884123-25-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1094038/000188412325000010/primary_doc.xml","form_type":"4"}},{"id":1749387,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":73641,"kind":"person","name":"Corzo Kathryn Penkus","position":1,"cik":"0001884123","reported_name":"Corzo Kathryn Penkus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-11-03T20:49:55.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":437244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":437244,"derivative":{"exercise_price":0.2088,"expiration_date":"2033-11-01","underlying":"Common Stock","underlying_shares":437244},"source":{"system":"sec-edgar","filing":"0001493152-23-039338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223039338/ownership.xml","form_type":"4"}},{"id":2114078,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":73641,"kind":"person","name":"Corzo Kathryn Penkus","position":1,"cik":"0001884123","reported_name":"Corzo Kathryn Penkus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-11-17T02:36:09.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":142657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":142657,"derivative":{"exercise_price":0.7268,"expiration_date":"2032-11-14","underlying":"Common Stock","underlying_shares":142657},"source":{"system":"sec-edgar","filing":"0001493152-22-032694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315222032694/ownership.xml","form_type":"4"}},{"id":2528215,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":73641,"kind":"person","name":"Corzo Kathryn Penkus","position":1,"cik":"0001884123","reported_name":"Corzo Kathryn Penkus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-11-02T20:13:49.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":181763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests in equal monthly installments over a period of 36 months commencing on November 30, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":181763,"derivative":{"exercise_price":1.12,"expiration_date":"2031-11-01","underlying":"Common Stock","underlying_shares":181763},"source":{"system":"sec-edgar","filing":"0001493152-21-026985","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315221026985/ownership.xml","form_type":"4"}}]}